慢性和高剂量类固醇治疗中的肺免疫性损伤
Mohleen Kang1, Rodrigo Cavallazzi2
1Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University School of Medicine, 615 Michael Street NE Suite 205, Atlanta, GA 30322, USA; Joseph Maxwell Cleland Atlanta VA Medical Center, Decatur, GA, USA.
Clinics in chest medicine
|January 31, 2025
概括
葡萄糖皮质类药物 (GCs) 广泛使用,但会增加感染风险. 本综述详细介绍了GC诱导的肺免疫损害,重点关注预防和管理策略,以尽量减少患者的并发症.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖皮质类药物 (GCs) 是各种疾病的必要治疗方法,包括肺,自身免疫,过敏和瘤疾病以及器官移植.
- 据估计,GC使用影响全球人口的1-2%,这凸显了其广泛应用.
- 草甘治疗与严重的传染性并发症有关,包括细菌,菌根和机会性感染,如肺炎和侵入性真菌感染.
研究的目的:
- 审查葡萄糖皮质激素处方的流行情况.
- 总结由GCs诱导的肺免疫性损害的机制和表现.
- 概述慢性和高剂量类固醇治疗患者感染管理的缓解策略.
主要方法:
- 关于葡萄糖皮质激素使用和相关的肺部并发症的研究文献综述.
- 在接受GCs的患者中分析感染的流行率和类型.
- 综合了关于GC机制,临床表现和预防措施的数据.
主要成果:
- GCs经常被用于许多疾病,在全球范围内使用量很大.
- 一系列的肺部感染,包括细菌,菌根和机会性病原体,与GC使用有关.
- 尽量减少GC剂量和持续时间对于降低感染风险至关重要.
结论:
- 肺免疫性损害是与慢性和高剂量葡萄糖皮质醇治疗相关的重大风险.
- 有效的管理需要对感染进行仔细监测,并实施尽量减少GC暴露的策略.
- 优化GC治疗包括平衡治疗效益与感染并发症风险.
相关概念视频
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
174
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
174
Immunodeficiency Diseases
895
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
895
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K


